ZAPPIA, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 26.425
EU - Europa 10.513
AS - Asia 10.004
SA - Sud America 2.125
AF - Africa 1.297
Continente sconosciuto - Info sul continente non disponibili 31
OC - Oceania 28
AN - Antartide 1
Totale 50.424
Nazione #
US - Stati Uniti d'America 25.306
SG - Singapore 4.837
CN - Cina 3.883
IE - Irlanda 2.891
IT - Italia 2.683
UA - Ucraina 2.033
BR - Brasile 1.870
CA - Canada 1.020
RU - Federazione Russa 834
CI - Costa d'Avorio 816
DE - Germania 594
VN - Vietnam 310
SN - Senegal 297
SE - Svezia 269
GB - Regno Unito 258
IN - India 242
FI - Finlandia 228
KR - Corea 199
FR - Francia 179
CH - Svizzera 103
AR - Argentina 87
NL - Olanda 86
PL - Polonia 75
UZ - Uzbekistan 74
MX - Messico 62
AT - Austria 59
BD - Bangladesh 56
IQ - Iraq 52
ZA - Sudafrica 52
TR - Turchia 50
ES - Italia 49
EC - Ecuador 44
GR - Grecia 39
NG - Nigeria 37
VE - Venezuela 35
HK - Hong Kong 34
JP - Giappone 34
MA - Marocco 32
EU - Europa 31
LB - Libano 31
PK - Pakistan 31
CO - Colombia 30
ID - Indonesia 26
AU - Australia 24
CL - Cile 24
IR - Iran 24
BG - Bulgaria 23
SA - Arabia Saudita 21
BE - Belgio 20
CZ - Repubblica Ceca 19
EG - Egitto 14
IL - Israele 14
PY - Paraguay 13
KE - Kenya 12
TN - Tunisia 12
LT - Lituania 11
NP - Nepal 11
AZ - Azerbaigian 10
RO - Romania 10
DZ - Algeria 9
JO - Giordania 9
HR - Croazia 8
KZ - Kazakistan 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
BH - Bahrain 7
BO - Bolivia 7
OM - Oman 7
AL - Albania 6
PA - Panama 6
PE - Perù 6
HN - Honduras 5
JM - Giamaica 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
GH - Ghana 4
HU - Ungheria 4
KG - Kirghizistan 4
MD - Moldavia 4
RS - Serbia 4
TW - Taiwan 4
AO - Angola 3
MN - Mongolia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
SV - El Salvador 3
BB - Barbados 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
KW - Kuwait 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
ML - Mali 2
MT - Malta 2
NI - Nicaragua 2
PT - Portogallo 2
Totale 50.397
Città #
Dallas 5.001
Santa Clara 3.214
Singapore 2.910
Dublin 2.883
Chandler 2.763
Jacksonville 2.115
Boardman 1.206
Nanjing 953
Abidjan 816
Cambridge 812
Lawrence 812
Ashburn 800
Andover 791
Chicago 762
Toronto 744
Houston 638
Catania 554
Hefei 459
Wilmington 363
San Mateo 348
Des Moines 322
Beijing 320
Civitanova Marche 312
Dakar 297
Munich 284
Los Angeles 279
Nanchang 272
Shenyang 248
Hebei 230
Ottawa 206
Seoul 198
Saint Petersburg 197
Jiaxing 191
Changsha 181
Helsinki 171
São Paulo 146
Tianjin 138
Dong Ket 118
Bremen 99
Pune 97
Norwalk 96
Milan 94
Council Bluffs 92
Moscow 82
Grafing 78
Jinan 78
Rome 75
Civitavecchia 73
Ho Chi Minh City 73
The Dalles 72
Seattle 71
New York 69
Padova 64
Columbus 61
Ningbo 59
San Francisco 56
Washington 55
Rio de Janeiro 52
Zhengzhou 49
Belo Horizonte 47
Hangzhou 42
Messina 40
Naples 39
Brooklyn 38
Hanoi 38
Den Haag 37
Liberty Lake 36
Palermo 36
Taizhou 35
Abuja 34
Ann Arbor 34
Boston 34
Guangzhou 34
Mumbai 34
Warsaw 33
Lappeenranta 31
Stockholm 31
Augusta 30
Montreal 30
Fairfield 29
London 29
Tokyo 29
Chennai 28
Johannesburg 28
Phoenix 28
Falls Church 27
Kunming 27
Redwood City 27
Brasília 26
Hong Kong 26
Tashkent 26
Atlanta 25
Leawood 25
Ribeirão Preto 24
Campinas 23
Salvador 23
Baghdad 22
Brussels 20
Amsterdam 19
Frankfurt Am Main 19
Totale 35.842
Nome #
Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis 361
Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study 313
A case of multiple autoimmunity complicated by SIADH 252
A Case of Apraxic Agraphia in a Patient With Progressive Supranuclear Palsy 242
6. Efficacy of a computer-assisted cognitive rehabilitation protocol on walking in Parkinson's disease patients with freezing of gait: a pilot study 233
Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations 185
1, 4-Benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 165
Indice di asimmetria striatale alla SPECT con DaT-SCAN e ampiezza di risposta al test acuto alla levodopa 143
1. Dopaminergic and non-dopaminergic effects on instrumented Timed Up and Go Test in patients with Parkinson’s disease 140
Restless Leg Sindrome (RLS) e Mioclono Periodico Notturno (PLM) in soggetto con manifestazioni ipercinetiche diurne 136
A pressure measurement for pull test validation in postural instability assessment 131
After the sweet comes the bitter. Time to halt the diabetic neuropathy epidemic 130
Hormetic approaches to the treatment of Parkinson's disease: Perspectives and possibilities 123
Management of dysphagia in multiple sclerosis: current best practice 123
Il Rasario. Semeiotica medica 122
A Comparison among Different Strategies to Detect Potential Unstable Behaviors in Postural Sway 116
PACAP and PAC1R are differentially expressed in motor cortex of amyotrophic lateral sclerosis patients and support survival of iPSC-derived motor neurons 114
Long-term efficacy of pregabalin in stiff person syndrome 112
Comparison of genioglossus muscle activity and efficiency of dexmedetomidine or propofol during drug-induced sleep endoscopy in patients with obstructive sleep apnea/hypopnea syndrome 111
Adult-Onset Sleepwalking Secondary to Hyperthyroidism: Polygraphic Evidence. 110
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 108
Incidence of multiple sclerosis in the province of Catania. A geo-epidemiological study 108
Living near waterbodies as a proxy of cyanobacteria exposure and risk of amyotrophic lateral sclerosis: a population based case-control study 108
UTILITÀ DIAGNOSTICA DELL’EEG IN SONNO DA SIESTA IN UN CAMPIONE DI PAZIENTI CON EPILESSIA MIOCLONICA GIOVANILE 106
Pattern of cortical excitability in patients with geriatric depression and subcortical ischemic vascular disease: a paired-pulse TMS study 106
Blink reflex recovery cycle to differentiate Progressive Supranuclear Palsy from Corticobasal Degeneration 106
Accuracy of MDS-UPDRS section IV for detecting motor fluctuations in Parkinson's disease 106
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 105
A Measurement System to Monitor Postural Behavior: Strategy Assessment and Classification Rating 105
A multisensor approach to perform instrumented postural instability tests for patient with Parkinson disease 104
Abnormal visual sensitivity in eyelid myoclonia with absences: Evidence from electrocortical connectivity and non-linear quantitative analysis of EEG signal 104
[(123) I]FP-CIT-SPECT asymmetry index to differentiate Parkinson's disease from vascular parkinsonism 102
Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome 102
Movimenti periodici agli arti inferiori durante sonno (PLMs) ed epilessia: associazione o comorbidità? [Periodic Leg Movements During Sleep (PLMs) and Epilepsy: Association or comorbidity?] 102
Dopaminergic and Non-Dopaminergic Gait Components Assessed by Instrumented Timed Up and Go Test in Parkinson's Disease 102
A Wearable Device to Support the Pull Test for Postural Instability Assessment in Parkinson's Disease 102
A Novel Exon 1 Mutation in a Patient with Atypical Lafora Progressive Myoclonus Epilepsy Seen as Childhood-onset Cognitive Deficit 102
A case of headache and idiopathic hypertrophic cranial pachymeningitis drastically improved after CSF tapping 100
Tremor pattern differentiates drug-induced resting tremor from Parkinson disease. 100
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 100
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 100
Cognitive dysfunction in multiple sclerosis. A population based study in Catania, Sicily 97
Computer-assisted cognitive rehabilitation on freezing of gait in Parkinson's disease: A pilot study 97
Diurnal fluctations of human nerve conduction velocity 96
An update on the safety of treating relapsing-remitting multiple sclerosis 96
A case of severe leg oedema in a patient with Parkinson's disease treated with pramipexole 95
Clinical phenotype correlates to glycoprotein phenotype in a sib pair with CDG-Ia 95
A screening questionnaire for generalized tonic‐clonic seizures: Hospital‐based validation vs field‐validation method 95
Increasing the Coding Potential of Genomes Through Alternative Splicing: The Case of PARK2 Gene. 94
Motor cortex excitability in patients with vascular cognitive impairment-no dementia: a follow-up study 93
Dopaminergic and non-dopaminergic effects on instrumented timed up and go test in patients with Parkinson's disease 92
Temperament traits and executive functions in Parkinson's disease 92
Neurophysiological tests in Multiple Sclerosis. A synthetic overview. 92
Acute motor effects induced by opioid antagonists in Parkinson’s disease: could naloxone be a rescue therapy? 92
Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal degeneration: A pilot study 91
Complexity of electrocortical activity as potential biomarker in untreated Parkinson’s disease 91
Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease 91
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily 90
Clinical Presentation and Outcome of Geriatric Depression in Subcortical Ischemic Vascular Disease 90
Man-in-the-barrel syndrome due to Klippel-Feil deformity 90
Movement Time Analyzer: A useful tool to evaluate bradykinesia and antiparkinsonian drugs in Parkinson's disease 90
Assessment of cervical myelopathy using transcranial magnetic stimulation in patients with Mucopolysaccharidosis 90
A case of Marburg variant multiple sclerosis: clinical impact after high dose cyclophosphamide treatment 90
Differential diagnosis of the main transient global amnesias atypical case report 90
Cardiovascular autonomic function and MCI in Parkinson's disease 90
Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy 90
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 89
11. Motor fluctuations evaluated by clinical assessments and self-reports in Parkinson’s disease. A waking-day monitoring study 89
Influence of RBD onset on the clinical characteristics of Parkinson's disease patients: a retrospective study 88
A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily: an update 88
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 88
Quantitative estimation of motor fluctuations in Parkinson's disease 88
ALS dysphagia pathophysiology: Differential botulinum toxin response 87
ATTIVITÀ EEG CON POLIPUNTE RAPIDE DIFFUSE DURANTE SONNO LENTO NELL’EPILESSIA CON ASSENZE GIOVANILI: CASO CLINICO 87
A case of idiopatic hypertrophic cranial pachymeningitis drastically improbe after CSF removal 87
Executive functions and cerebellum in spinocerebellar ataxia type 2: a volumetric study. 87
Validation of the Italian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale 87
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 86
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 86
Knowledge, stigma, and quality of life in epilepsy: Results before and after a community-based epilepsy awareness program in rural Bolivia 86
MULTIDISCIPLINARY APPROACH OF AMYOTROPHICLATERAL SCLEROSIS:A CENTRE EXPERIENCE 85
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy 85
The PRIAMO study: background, methods and recruitment 85
A case of apraxic agraphia in a patient with Progressive Supranuclear Palsy. 85
Metals and neurodegenerative diseases. A systematic review 85
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 85
Comment to: Trace elements in ALS patients and their relationships with clinical severity, by Oggiano R. et al 85
Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis 85
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease 84
Obsessive compulsive personality disorder and parkinson's disease 84
Pregabalin for essential tremor 84
Dissociation between motor and cognitive impairments in SCA2: Evidence from a follow-up study 84
Subclinical rhythmic electrographic discharge of adults (SREDA) during sleep: a rare insidiuous EEG pattern in the clinical practice 84
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 84
Possible increasing risk of multiple sclerosis in Catania, Sicily 83
When the word doesn't come out: A synthetic overview of dysarthria 83
Executive functions, apathy and temperament in Parkinson’s disease 83
CCSVI and MS. A population-based case-control study in Catania, Sicily. 83
Base-peak assessment of levodopa response and detection of fluctuating patients in Parkinson's disease 83
Post-Cerebrovascular Stroke and Early Dysphagia Assessment: A Systematic Review 82
Totale 10.753
Categoria #
all - tutte 203.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.039 0 0 0 25 1.295 92 363 22 388 87 485 282
2021/20225.800 783 827 69 68 899 40 869 171 496 21 267 1.290
2022/20239.003 876 340 95 719 913 1.600 24 1.635 2.301 75 305 120
2023/20243.759 192 542 188 194 172 831 101 272 46 138 675 408
2024/202513.981 118 1.927 975 543 3.085 1.375 428 679 1.285 1.558 851 1.157
2025/20268.619 1.699 1.195 5.432 293 0 0 0 0 0 0 0 0
Totale 51.721